PDPL
- Series
- BE
- F&O
- No
- Status
- Inactive since 02 Apr 2019
Source: NSE equity master · as of 01 Apr 2019
- 20 Jun 2022 16:58PDF · -Results
PDPL : The Exchange had sought clarification from Parenteral Drugs (India) Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is enclosed.
- 15 Jun 2022 13:25Results
PDPL : The Exchange has sought clarification from Parenteral Drugs (India) Limited for the quarter ended 31-Mar-2022 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is awaited.
- 31 May 2022 11:55PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.
- 30 May 2022 18:23PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.
- 14 Feb 2022 18:04PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2021.
- 12 Nov 2021 17:45PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2021.
- 10 Aug 2021 17:53PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended June 30, 2021.
- 22 Jul 2021 20:24PDF · -Results
The Exchange had sought clarification from Parenteral Drugs (India) Limited for the quarter ended 31-Mar-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is enclosed.
- 15 Jul 2021 23:42Results
The Exchange has sought clarification from Parenteral Drugs (India) Limited for the quarter ended 31-Mar-2021 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Limited Review Report/ Independent Auditor's Report is not in the format prescribed by SEBI The response of the Company is awaited.
- 09 Jul 2021 14:57PDF · -Results
Parenteral Drugs (India) Limited hereby inform regarding Resubmission of Annual Audited Financial Results on Consolidated basis for the Financial Year ended 31st March, 2021 (XBRL) due to clerical error
- 30 Jun 2021 18:24PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2021.
- 12 Feb 2021 17:37PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2020.
- 10 Nov 2020 17:38PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2020.
- 25 Aug 2020 14:37PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended June 30, 2020.
- 25 Aug 2020 13:36PDF · -Results
Parenteral Drugs (India ) Limited hereby submits Quarterly Unaudited Financial Results (on both Standalone and Consolidated basis) of the Company for the financial year 2020-21 ended on 30th June, 2020.
- 29 Jul 2020 14:59PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2020.
- 12 Feb 2020 14:01PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2019.
- 13 Nov 2019 15:18PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2019.
- 05 Aug 2019 18:52PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended June 30, 2019.
- 30 May 2019 16:58PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2019.
- 14 Feb 2019 18:05PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2018.
- 13 Nov 2018 16:05PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2018.
- 14 Aug 2018 16:50PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended June 30, 2018.
- 10 Jul 2018 14:48PDF · -Results
The Exchange had sought clarification from Parenteral Drugs (India) Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Standalone Reconciliation of Equity not submitted -2. Consolidated Reconciliation of Equity not submitted The response of the Company is enclosed.
- 03 Jul 2018 19:34Results
The Exchange has sought clarification from Parenteral Drugs (India) Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Standalone Reconciliation of Equity not submitted -2. Consolidated Reconciliation of Equity not submitted The response of the Company is awaited.
- 29 Jun 2018 16:27PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2018.
- 16 Feb 2018 10:46PDF · -Results
The Exchange had sought clarification from Parenteral Drugs (India) Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Standalone limited review report not submitted. -2. Consolidated limited review report not submitted. The response of the Company is enclosed.
- 15 Feb 2018 12:03Results
The Exchange has sought clarification from Parenteral Drugs (India) Limited with respect to Non-compliance as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. Standalone limited review report not submitted. -2. Consolidated limited review report not submitted. The response of the Company is awaited.
- 14 Feb 2018 20:26PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2017.
- 14 Dec 2017 16:36PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2017.
- 14 Sept 2017 14:46PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended June 30, 2017.
- 30 May 2017 17:48PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended March 31, 2017.
- 13 Feb 2017 15:25PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended December 31, 2016.
- 14 Nov 2016 14:25PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange, the financial results for the period ended September 30, 2016.
- 12 Aug 2016 14:29PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended June 30, 2016.
- 30 May 2016 16:46PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange the standalone & consolidated financial results along with the Auditors Report for the period ended March 31, 2016.
- 30 May 2016 16:41PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange the standalone & consolidated financial results along with the Auditors Report for the period ended March 31, 2016.
- 13 Feb 2016 16:07PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended December 31, 2015.
- 09 Nov 2015 16:16PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange a copy of the Un-audited Financial Results (both Standalone and Consolidated) of the company for the quarter ended September 30, 2015. (Revised)
- 09 Nov 2015 13:56PDF · -Results
Parenteral Drugs (India) Limited has submitted to the exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended 30-Sep-2015.
- 18 Jul 2015 16:12PDF · -Results
Parenteral Drugs (India) Limited has submitted to the exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended 30-Jun-2015.
- 30 May 2015 19:43PDF · -Results
Parenteral Drugs (India) Limited has submitted to the exchange the standalone & consolidated financial results along with the Auditors Report for the period ended 31-Mar-2015.
- 10 Feb 2015 18:19PDF · -Results
Parenteral Drugs (India) Limited has submitted to the exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended 31-Dec-2014.
- 14 Nov 2014 16:43PDF · -Results
Parenteral Drugs (India) Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 30-Sep-2014.
- 14 Aug 2014 16:19PDF · -Results
Parenteral Drugs (India) Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 30-Jun-2014.
- 30 May 2014 15:19PDF · -Results
Parenteral Drugs (India) Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-Mar-2014.
- 14 Feb 2014 16:03PDF · -Results
Parenteral Drugs (India) Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 31-dec-2013.
- 14 Nov 2013 13:43PDF · -Results
Parenteral Drugs (India) Limited has submitted to the exchange the standalone & consolidated financial results for the period ended 30-sep-2013.
- 13 Aug 2013 15:20PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended June 30,2013.
- 31 May 2013 11:20PDF · -Results
Parenteral Drugs (India) Limited has submitted to the Exchange the Standalone and Consolidated Financial Results for the period ended March 31,2013.
- Results & board-meeting calendar
- Dividend, split, AGM calendar
- Headlines with source and timestamp
- Two-line factual filing summaries